diabetestalk.net

Carmel Valley Resident Joins More Than 180 Diabetes Advocates For The American Diabetes Associations 2017 Call To Congress Advocacy Day

Carmel Valley resident joins more than 180 diabetes advocates for the American Diabetes Associations 2017 Call to Congress Advocacy Day

Carmel Valley resident joins more than 180 diabetes advocates for the American Diabetes Associations 2017 Call to Congress Advocacy Day


Carmel Valley resident joins more than 180 diabetes advocates for the American Diabetes Associations 2017 Call to Congress Advocacy Day
(L-R) Dr Alan Saltiel, Hillary Liber, Honorable Susan Davis, Basma Abdellaoui, Rachida Abdellaoui, and Chief of Staff Matt Weiner
(L-R) Dr Alan Saltiel, Hillary Liber, Honorable Susan Davis, Basma Abdellaoui, Rachida Abdellaoui, and Chief of Staff Matt Weiner (Courtesy)
. More than 180 advocates from 33 states convened at the U.S. Capitol in Washington, D.C., for the American Diabetes Associations 2017 Call to Congress advocacy day.
The advocates, including adults and children living with type 1 and type 2 diabetes, family members of people with diabetes, researchers, physicians and diabetes care providers, participated in 188 meetings with their members of Congress and urged them to address the diabetes epidemic. In addition to people with diabetes and health care providers, advocates included more than 30 members of Team Tackle an initiative to engage professional football players to raise awareness of diabetes and prediabetes.
During the March 30 press conference, the Association outlined the state of the diabetes epidemic and called on Congress to protect access to adequate health insurance for people living with diabetes, to increase federal funding to support and drive diabetes research and programs, and to ensure that lifesaving insulin is accessible for all who need it. The Association remains dedicated to protecting the
Patient Protection and Affordable Care Act
(ACA) from repeal without an immediate replacement that prov Continue reading

Rate this article
Total 1 ratings
Can a dual-hormone closed loop delivery systems become a “technical cure” of diabetes?

Can a dual-hormone closed loop delivery systems become a “technical cure” of diabetes?

The dual hormone (insulin and glucagon) ‘‘artificial pancreas’’: Promises and challenges
Achieving tight glycaemic control without severe hypoglycaemia still is a major challenge in insulin-treated diabetes. While curative cell based and immunological therapies could theoretically provide the ideal solution for patients with diabetes, there are still many issues to be solved. Closed-loop technologies may provide a more promising alternative for the near future, although various challenges will still need to be overcome to safely avoid hypoglycaemia and still achieve good blood glucose levels in a closed-loop setting.
From a controlling perspective, a major challenge is the use of exogenous subcutaneously (s.c.) applied insulin with a rather slow onset and long duration of action, which is unable to react fast enough to the wide and highly variable range in insulin requirements under different physiological conditions. To put a physiological break on the insulin action when blood glucose tends to go low, bihormonal artificial pancreas (AP) systems are being developed which, in addition to insulin, use human pancreas hormone glucagon to counteract the effect of insulin. Glucagon leads to a rapid conversion of hepatic glycogen (the stored form of glucose) into glucose which is then released into the bloodstream. A number of academic working groups have demonstrated short-term efficacy and safety of automated insulin and glucagon delivery among people with type 1 diabetes mellitus [[i]] [[ii]] [[iii]] [[iv]]. Glucagon’s effects on reducing caloric intake and increasin Continue reading

Dietary Supplements: Hype or Helpful?

Dietary Supplements: Hype or Helpful?


More than half of Americans take dietary supplements . You probably have a bottle of vitamins or an herbal supplement in your cupboard or medicine cabinet (I know I do!). The dietary supplement industry is big business the projection is that by 2024, the supplement market will reach $278 billion . Supplements are touted everywhere in drugstores, grocery stores, health-food stores, and, of course, on the Internet. Plus, entire stores (GNC, Vitamin Shoppe) are devoted to selling pills and potions to enhance health and performance. And lets not forget the celebrities and sports stars pushing supplements on us, as well. But are dietary supplements all theyre cracked up to be? Does swallowing a fistful of pills every morning really make you healthier?
Dietary supplements encompass a whole host of items , including vitamins and minerals, herbs and other botanicals, enzymes, and amino acids. Supplements come in a variety of forms tablets, capsules, softgels, gelcaps, liquids, and powders. Some common supplements include:
Are dietary supplements approved by the FDA?
According to the FDA , a dietary supplement is a product intended for ingestion that contains a dietary ingredient intended to add further nutritional value to (supplement) the diet. From that definition, taking a supplement sounds like a pretty good idea. Taking a multivitamin every day, for example, seems pretty benign, and for the most part, it is. However, the FDA does not approve dietary supplements. This means that supplement manufacturers are not required to obtain FDA approval to market their products. Continue reading

Study finds increasing trends in new diagnosed cases of type 1 and type 2 diabetes among youth

Study finds increasing trends in new diagnosed cases of type 1 and type 2 diabetes among youth

Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report, Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012, published today in the New England Journal of Medicine.
In the United States, 29.1 million people are living with diagnosed or undiagnosed diabetes, and about 208,000 people younger than 20 years are living with diagnosed diabetes.
This study is the first ever to estimate trends in new diagnosed cases of type 1 and type 2 diabetes in youth (those under the age of 20), from the five major racial/ethnic groups in the U.S.: non-Hispanic whites, non-Hispanic blacks, Hispanics, Asian Americans/Pacific Islanders, and Native Americans. However, the Native American youth who participated in the SEARCH study are not representative of all Native American youth in the United States. Thus, these rates cannot be generalized to all Native American youth nationwide.
The SEARCH for Diabetes in Youth study, funded by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), found that from 2002 to 2012, incidence, or the rate of new diagnosed cases of type 1 diabetes in youth increased by about 1.8 percent each year. During the same period, the rate of new diagnosed cases of type 2 diabetes increased even more quickly, at 4.8 percent. The study included 11,244 youth ages 0-19 with type 1 diabetes and 2,846 youth ages 10-19 with type 2.
"Because of the early age of onset and longer diabetes duration, youth are at risk for developing diabetes related com Continue reading

Summiting Mt. Everest with Diabetes: Is It Possible?

Summiting Mt. Everest with Diabetes: Is It Possible?


By Elisabeth Almekinder RN, BA, CDE Leave a Comment
Sometimes, you meet the most incredible people, who challenge themselves as athletes with diabetes. In this article, we will meet three mountain climbers and athletes with Type 1 Diabetes who have made summit on Mt. Everest. They represent the countries of Spain, Canada, and the United States.
Whats so incredible about these three men, is that they have beat several sets of odds by making it not only to the summit of Mt. Everest, but down again. The fact is, more people die on the way down from Mt. Everest, after they have completed their dream of reaching the summit.
Since alpiners began climbing Everest back in 1921, there have been 290 people who have died. Its estimated that of those, over 120 dead bodies still lie in rest on the mountain.
Lets learn about our three Type 1 climbers:
In the order of ascent, we will interview Josu Fiejoo from Spain, who you may remember from the recent article here on astronauts , and Will Cross from the USA, Sebastien Sasseville from Canada. Lets see how these incredible athletes with diabetes conquered the highest mountain in the world, a mountain that has taken the lives of many healthy hikers with no chronic condition whatsoever.
Josu Feijoo, Spain summited May 18, 2006
Sebastien Sasseville, Canada summited May 25, 2008
Their stories are inspiring to others, no matter what their goals. The moral is, even when climbing the highest mountain, you should not let diabetes stand in your way. Most of you will not attempt to climb Mt. Everest, but these stories show us that it ca Continue reading

No more pages to load

Popular Articles

Related Articles